Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
[ Research Compound Architecture ] CJC-1295 Ipamorelin GHRP-2 (GHRH Agonist) (Highly Selective) (Potent GHS) [ Target: Pituitary/GHS-R ] To understand the blend, it helps to look at its individual components: CJC-1295 (Mod GRF 1-29): This is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH)
While many people notice an improvement in their health soon after starting peptide therapy, it can take several weeks to experience the effects of therapy
As a cooperative, IPC is committed to the success of our members and offers select vendor partners exclusively to our GPO membership
In a 12-week clinical study, obese participants taking 1 mg of AOD-9604 daily lost about 2.62.8 kg (56 lbs) on average more than triple the weight loss of the placebo group
Muoio, D
[PubMed: 8501164] 125
US$ 24.95
US$ 28.04
US$ 22.27
US$ 22.12
US$ 21.84
US$ 27.02
